CONMED (NYSE:CNMD – Get Free Report) updated its FY24 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of $4.25-4.35 for the period, compared to the consensus estimate of $4.33. The company issued revenue guidance of $1.330-1.355 billion, compared to the consensus revenue estimate of $1.35 billion. CONMED also updated its FY […]
CONMED (NYSE:CNMD – Get Free Report) updated its FY24 earnings guidance on Wednesday. The company provided EPS guidance of $4.25-4.35 for the period, compared to the consensus EPS estimate of $4.33. The company issued revenue guidance of $1.330-1.355 billion, compared to the consensus revenue estimate of $1.35 billion. CONMED also updated its FY 2024 guidance […]
Bahl & Gaynor Inc. boosted its holdings in CONMED Co. (NYSE:CNMD – Free Report) by 1.4% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 15,434 shares of the company’s stock after buying an additional 207 shares during the quarter. Bahl & Gaynor Inc. owned […]
Bahl & Gaynor Inc. boosted its position in CONMED Co. (NYSE:CNMD – Free Report) by 1.4% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 15,434 shares of the company’s stock after purchasing an additional 207 shares during the period. Bahl & Gaynor Inc.’s holdings in CONMED were […]
Bahl & Gaynor Inc. boosted its holdings in CONMED Co. (NYSE:CNMD – Free Report) by 1.4% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 15,434 shares of the company’s stock after buying an additional 207 shares during the quarter. Bahl & Gaynor Inc. owned […]